Astec Lifesciences consolidated net profit rises 101.87% in the September 2022 quarter
Sales rise 94.75% to Rs 199.75 crore
Net profit of Astec Lifesciences rose 101.87% to Rs 18.31 crore in the quarter ended September 2022 as against Rs 9.07 crore during the previous quarter ended September 2021. Sales rose 94.75% to Rs 199.75 crore in the quarter ended September 2022 as against Rs 102.57 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales199.75102.57 95 OPM %16.6620.55 -PBDT32.7520.33 61 PBT24.5812.18 102 NP18.319.07 102Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content